Leapcure - About the company
Leapcure is a seed company based in Los Angeles (United States), founded in 2015 by Tyler Dornenburg. It operates as a Connecting patients with clinical trials, prioritizing patient voices for equitable research. Leapcure has raised an undisclosed amount in funding. The company has 168 active competitors, including 45 funded and 16 that have exited. Its top competitors include companies like Evidation, myTomorrows and Antidote.
Company Details
Connecting patients with clinical trials, prioritizing patient voices for equitable research. This organization focuses on making research more equitable and efficient by placing patient advocacy at the forefront. They partner with advocacy groups, health influencers, and community leaders to ensure patient experiences are prioritized for clinical trial researchers. The goal is to accelerate research outcomes by understanding and meeting patient needs. They empower advocacy groups with technology to maximize their impact on research, improving patient outcomes by listening to study teams, physicians, and sponsors. Their innovative technology and empathetic approach aim to advance medical breakthroughs for everyone, fostering inclusivity and diversity in clinical research. They offer a platform for patients to share their stories, contributing to a deeper understanding of patient perspectives in the research process. This is a B2B model, offering SaaS and software solutions to connect patients, researchers, and sponsors, driving progress in clinical trials through patient-centered innovation.
- Website
- leapcure.com
Key Metrics
Founded Year
2015
Location
Los Angeles, United States
Stage
Seed
Latest Funding Round
Investors
Ranked
44th among 168 active competitors
Employee Count
65 as on May 31, 2026
Investment & Acquisitions
Sign up to download Leapcure's company profile
Leapcure's funding and investors
Leapcure has raised funding over 1 round. Its latest funding round was a Seed round on Aug 01, 2016 for $*****. 1 investor participated in its latest round. Leapcure has 1 institutional investor.
Here is the list of recent funding rounds of Leapcure:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 01, 2016 | 7287125 | Seed | 5229474 | 9823846 | 8651194 | 6232628 |
View details of Leapcure's funding rounds and investors
Leapcure's founders and board of directors
Founder? Claim ProfileThe founders of Leapcure is Tyler Dornenburg.
Here are the details of Leapcure's key team members:
- Tyler Dornenburg: Director Of Partnerships (Cofounder) of Leapcure.
- Zachary Gobst: CEO of Leapcure.
View details of Leapcure's Founder profiles and Board Members
Leapcure's employee count trend
Leapcure has 65 employees as of May 26. Here is Leapcure's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Leapcure's Competitors and alternates
Top competitors of Leapcure include Evidation, myTomorrows and Antidote. Here is the list of Top 10 competitors of Leapcure, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Evidation 2012, Menlo Park (United States), Series E | Real-world health data insights for better healthcare decisions and research | $259M | 74/100 | |
2nd | myTomorrows 2012, Amsterdam (Netherlands), Series C | Platform provides access to drugs in development to patients and physicians | $51.3M | 69/100 | |
3rd | Antidote 2010, North Miami Beach (United States), Series C | Provider of patient recruitment and matching services for clinical trials | $52M | 65/100 | |
4th | SubjectWell 2012, Austin (United States), Acquired | Provider of clinical trials marketplace offering solutions for patient recruitment | $46.8M | 60/100 | |
5th | Dyania Health 2019, Sacramento (United States), Series A | Developer of an AI platform for healthcare data extraction and analysis | $15.3M | 60/100 | |
6th | Cloud based clinical trial recruitment solutions for pharmaceutical companies, analytics, services | $27.1M | 59/100 | ||
7th | Circuit Clinical 2014, Buffalo (United States), Series C | Research site network platform focuses on patient identification, enrollment, recruitment & retention | $47.7M | 58/100 | |
8th | Paradigm 2003, New York City (United States), Series A | Provider of clinical research healthcare services | $203M | 55/100 | |
9th | Leal 2017, New York City (United States), Acquired | Provider of an AI-powered platform matching cancer patients with treatment options. | $27.7M | 55/100 | |
10th | BEKHealth 2016, New York City (United States), Series C | Provider of patient screening, recruitment, and analytics solution | $15.7M | 54/100 | |
44th | Leapcure 2015, Los Angeles (United States), Seed | Connecting patients with clinical trials, prioritizing patient voices for equitable research | - | 22/100 |
Looking for more details on Leapcure's competitors? Click here to see the top ones
Leapcure's Investments and acquisitions
Leapcure has acquired Honeybee Hub. Leapcure has not made any investments as of now.News related to Leapcure
Media has covered Leapcure for 1 event in last 1 year, It was about company updates.
•
Leapcure Launches Leap Together Podcast Sharing Human Stories in Clinical ResearchPR Newswire•Jun 02, 2025•Leapcure
•
•
•
Leapcure Expands Clinical Trial Service Offerings to Medical Device Clinical TrialsMedical Product Outsourcing•Dec 17, 2019•Leapcure
•
Here’s the 18th batch of companies from 500 StartupsTechCrunch+•Aug 02, 2016•Auctio, Avicennas, Fragmentic, Fan Stream and 40 others
Are you a Founder ?
FAQs about Leapcure
Explore our recently published companies
- Theaiparagonconsulting - Unfunded company
- Thorncapstead Shop - Unfunded company
- Dashlexapro300 - Unfunded company
- Trysuperpower - Unfunded company
- Ashvamedhaai - Unfunded company
- Dzemat-Sabah - 2008 founded, Unfunded company